CompaniesByCap
VRDN
Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare

Viridian Therapeutics Inc. Income Statement 2013–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Revenues
Revenue70.8M302,000314,0001.8M3.0M1.1M4.5M8.4M4.0M3.5M5.7M6.5M5.5M
Gross Profit
Profitability
Operating Income-363.4M-299.0M-254.4M-134.3M-79.7M-110.4M-42.0M-33.1M-26.5M-17.0M-11.2M-6.9M-197,000
EBITDA
Net Income-342.6M-269.9M-237.7M-129.9M-79.4M-110.7M-41.9M-32.7M-26.5M-17.3M-11.3M-7.9M-2.2M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)102M81M45M32M12M4M2M31M23M1M1M4M0M

Viridian Therapeutics Inc. Income Statement — FAQ

Viridian Therapeutics Inc. (VRDN) income statement over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VRDN's income statement history?

The chart and table above show Viridian Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.